Effect of certolizumab pegol over ninety-six weeks in patients with axial spondyloarthritis: Results from a phase III randomized trial

J. Sieper, R. Landewé, M. Rudwaleit, D. Van Der Heijde, M. Dougados, P. J. Mease, J. Braun, A. Deodhar, A. Kivitz, J. Walsh, B. Hoepken, T. Nurminen, W. P. Maksymowych

Research output: Contribution to journal › Article › peer-review

47 Scopus citations

Fingerprint

Dive into the research topics of 'Effect of certolizumab pegol over ninety-six weeks in patients with axial spondyloarthritis: Results from a phase III randomized trial'. Together they form a unique fingerprint.

Medicine & Life Sciences